FIBROLAMELLAR
CANCER FOUNDATION
We are here to help.
FIBROLAMELLAR
CANCER FOUNDATION
We are here to help.
Announcements
- Duke University Research Conversation and Facilities Tour The Fibrolamellar Cancer Foundation cordially invites you to a VIP Research event hosted by Dr. Anna Mae Diehl, Professor, Department of Medicine at Duke University and by Dr. Cynthia Guy, Associate Professor, Department of Pathology at Duke University Medical Center, on Monday, October 29, 2018,12:00p.m. – 2:30 p.m. The event will showcase the important fibrolamellar research work being conducted […]
- FCF Scientific Director Mark Furth, PhD, has joined FCF as Scientific Director. Having a full time scientific director adds a new realm of professionalism. Dr. Furth was educated at Harvard and University of Wisconsin. His research credentials include working at National Institute of Health, Memorial Sloan Kettering, Cold Spring Harbor Laboratories, Glaxo Smith Kline and Wake Forest University.
- Social Security Agency Expands Compassionate Allowance List Nancy A. Berryhill, Acting Commissioner of Social Security, announced five new Compassionate Allowance conditions: Fibrolamellar Cancer, Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (MMIHS), Megalencephaly Capillary Malformation Syndrome (MCAP), Superficial Siderosis of the Central Nervous System, and Tetrasomy 18p. Compassionate Allowances is a program to quickly identify medical conditions and serious diseases that meet Social Security’s standards for […]
- Advocates and scientists connect during Fibrolamellar Cancer Foundation visit to Cornell University The Fibrolamellar Cancer Foundation (FCF) recently held a research event at Cornell University hosted by Praveen Sethupathy, Ph.D ’03, Associate Professor of Biomedical Sciences, who presented to fellow researchers, Foundation board members, and a patient and his family. Dr. Sethupathy reviewed his current research toward finding therapeutic targets to fight fibrolamellar cancer. Cornell University issued […]
